Emerging evidence has implicated MAML1 as an exciting key transcriptional coactivators in other signal transduction pathways, including muscle differentiation and myopathies (MEF2C), tumor suppressor pathway (p53), and colon carcinoma survival (β-catenin). The gene discussed is TP53; the disease is colon carcinoma.